Results
1 -
8 of
8Novel Approaches in Melanoma Prevention and Therapy, Advances in Nutrition and Cancer Melanoma 2014u2014an update, memo - Magazine of European Medical Oncology Antineoplastics, Reactions Weekly Encorafenib, Reactions Weekly Phase Ib/II, open-label, dose-escalation study of LGX818, an oral selective BRAF inhibitor, in combination with MEK162, an oral MEK1/2 inhibitor, in patients with BRAF V600-dependent advanced solid tumors: preliminary results, Journal of Translational Medicine B-Raf and the inhibitors: from bench to bedside, Journal of Hematology & Oncology Clinical observation of panniculitis in two patients with BRAF-mutated metastatic melanoma treated with a combination of a BRAF inhibitor and a MEK inhibitor, European Journal of Dermatology Putting SMYD3 on the MAP, Science-Business eXchange